healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
kapur_0000_cohort_treatment-with-eptinezumab-reduces-brain-fog-and-increases-the-number-of-good-days-per-month-in-patients-with-chronic-migraine-in-a-real-world-setting
1 finding
Protocol
medication-eptinezumab-intravenous-monthly-migraine-chronic-protocol
Outcome
brain-fog-severity-improvement-rating-self-reported
n
94
effect
70
attribution
20